Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC332710204;10205;10206 chr2:178764536;178764535;178764534chr2:179629263;179629262;179629261
N2AB332710204;10205;10206 chr2:178764536;178764535;178764534chr2:179629263;179629262;179629261
N2A332710204;10205;10206 chr2:178764536;178764535;178764534chr2:179629263;179629262;179629261
N2B328110066;10067;10068 chr2:178764536;178764535;178764534chr2:179629263;179629262;179629261
Novex-1328110066;10067;10068 chr2:178764536;178764535;178764534chr2:179629263;179629262;179629261
Novex-2328110066;10067;10068 chr2:178764536;178764535;178764534chr2:179629263;179629262;179629261
Novex-3332710204;10205;10206 chr2:178764536;178764535;178764534chr2:179629263;179629262;179629261

Information

  • RefSeq wild type amino acid: S
  • RefSeq wild type transcript codon: TCA
  • RefSeq wild type template codon: AGT
  • Domain: Ig-23
  • Domain position: 89
  • Structural Position: 175
  • Q(SASA): 0.3769
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
S/L rs1561162422 None 0.473 N 0.515 0.258 0.626644753645 gnomAD-2.1.1 3.99E-06 None None None None N None 0 0 None 9.93E-05 0 None 0 None 0 0 0
S/L rs1561162422 None 0.473 N 0.515 0.258 0.626644753645 gnomAD-4.0.0 1.59069E-06 None None None None N None 0 0 None 4.76554E-05 0 None 0 0 0 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
S/A 0.0818 likely_benign 0.0872 benign -0.764 Destabilizing 0.27 N 0.359 neutral N 0.503468938 None None N
S/C 0.1892 likely_benign 0.1711 benign -0.622 Destabilizing 0.995 D 0.431 neutral None None None None N
S/D 0.4081 ambiguous 0.3712 ambiguous -0.132 Destabilizing 0.543 D 0.29 neutral None None None None N
S/E 0.4479 ambiguous 0.4398 ambiguous -0.163 Destabilizing 0.704 D 0.29 neutral None None None None N
S/F 0.1863 likely_benign 0.1698 benign -1.063 Destabilizing 0.007 N 0.389 neutral None None None None N
S/G 0.1852 likely_benign 0.1687 benign -0.966 Destabilizing 0.495 N 0.317 neutral None None None None N
S/H 0.2788 likely_benign 0.264 benign -1.437 Destabilizing 0.017 N 0.267 neutral None None None None N
S/I 0.1645 likely_benign 0.1566 benign -0.339 Destabilizing 0.704 D 0.538 neutral None None None None N
S/K 0.5619 ambiguous 0.5626 ambiguous -0.681 Destabilizing 0.704 D 0.291 neutral None None None None N
S/L 0.102 likely_benign 0.095 benign -0.339 Destabilizing 0.473 N 0.515 neutral N 0.500013251 None None N
S/M 0.2014 likely_benign 0.184 benign -0.094 Destabilizing 0.944 D 0.455 neutral None None None None N
S/N 0.1501 likely_benign 0.1378 benign -0.579 Destabilizing 0.013 N 0.065 neutral None None None None N
S/P 0.8446 likely_pathogenic 0.8803 pathogenic -0.449 Destabilizing 0.927 D 0.481 neutral D 0.628522039 None None N
S/Q 0.408 ambiguous 0.4159 ambiguous -0.801 Destabilizing 0.944 D 0.405 neutral None None None None N
S/R 0.4255 ambiguous 0.4438 ambiguous -0.518 Destabilizing 0.704 D 0.47 neutral None None None None N
S/T 0.0736 likely_benign 0.0668 benign -0.658 Destabilizing 0.01 N 0.068 neutral N 0.412806133 None None N
S/V 0.1791 likely_benign 0.1743 benign -0.449 Destabilizing 0.543 D 0.535 neutral None None None None N
S/W 0.3769 ambiguous 0.3267 benign -0.986 Destabilizing 0.995 D 0.551 neutral None None None None N
S/Y 0.1858 likely_benign 0.1775 benign -0.738 Destabilizing 0.807 D 0.532 neutral None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.